Stratix Labs

What Stratix Labs does

Stratix Labs is a Saint Paul, Minnesota-based microbiology product company founded in 2019 and operating with 1 to 10 employees. The company developed and marketed innovative microbiology products for research, development, and quality control applications, anchored by two core technology platforms: a proprietary microbial preservation technology for pharmaceutical manufacturing and compounding environments, and the Enverify Viable Surface Sampling Competency Kits designed to improve accuracy and precision in environmental monitoring. Its primary customer segment is pharmaceutical manufacturers — drug developers and compounders seeking robust microbial contamination control, sterility assurance, and regulatory compliance — with a secondary segment of pharmaceutical compounders requiring reliable quality control solutions for non-sterile and sterile preparations.

The business model centered on selling proprietary microbiology consumables and competency kits to enterprise pharmaceutical and compounding customers. Prior to acquisition, Stratix Labs operated as an independent private company funded through four small rounds totaling approximately $1.48 million between 2019 and 2022, with no publicly disclosed pricing. Commercial activity relied on direct enterprise sales to QA/QC and microbiology lab buyers in pharma manufacturing and compounding organizations.

In October 2024, Stratix Labs was acquired by USP (United States Pharmacopeia), a scientific nonprofit that develops quality standards for medicines, dietary supplements, and food ingredients. The acquisition integrated Stratix Labs' preservation technology and surface sampling solutions into USP's microbiology portfolio, leveraging USP's compendial authority since 1965, its global USP Store distribution channel, and its authorized distributor network to scale the products into pharmaceutical manufacturers and compounders worldwide.

Name

Stratix Labs

Legal name

Stratix Labs

Website

https://stratixlabs.com

Company type

Private

Founded year

2019

Operating status

Acquired

Headcount range

1–10 employees

Short description

Stratix Labs, founded in 2019 in Saint Paul, Minnesota, develops proprietary microbial preservation technology and Enverify surface sampling competency kits for pharmaceutical manufacturers and compounders. The company was acquired by USP in October 2024 to bolster its microbiology and quality control portfolio.

Ownership category

akta.pro rank

Product category

Pharmaceutical Microbiology Quality Control Products

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)

akta.pro secondary industry

Lab Safety, PPE & Contamination Control (Hoods, Biosafety Cabinets, Clean Air) (HLAGAIAK)

Keywords

• Microbial quality control
• Pharmaceutical microbiology
• Contamination control products
• Environmental monitoring kits
• Sterility assurance solutions

Headquarters

HQ city

Saint Paul

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Distribution channels2 records

Marketing channels4 records

Core offering

Stratix Labs develops and markets innovative microbiology products, including microbial preservation technology and surface sampling competency kits, for pharmaceutical manufacturing, compounding, research, development, and quality control applications. Following its 2024 acquisition by USP (United States Pharmacopeia), its offerings are now integrated into USP's microbiology portfolio to support sterility assurance and contamination control.

Product overview

Stratix Labs was a microbiology technology company focused on microbial preservation solutions. In October 2024, Stratix Labs was acquired by USP (United States Pharmacopeia) to enhance USP's microbiology portfolio. The company's innovative preservation technology has been integrated into USP's suite of microbiology quality control solutions, contributing to enhanced microbial contamination control in manufacturing and compounding environments.

Differentiator

Problem solved

Functional benefit

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• USP (United States Pharmacopeia)coreStrategic or Co-development Partner · 1 October 2024USP acquired Stratix Labs in October 2024 to enhance its microbiology portfolio with innovative technology. The acquisition brought Stratix Labs' preservation technology and surface sampling solutions under USP's umbrella, combining Stratix Labs' innovations with USP's established quality standards and regulatory expertise in the pharmaceutical industry.

Recent moves5 records

Expansion highlights4 records

Direct peers

• Hardy Diagnostics: Manufacturer of microbiology culture media, QC organisms, and environmental monitoring products for clinical, industrial, and pharmaceutical laboratories. Comparable to Stratix Labs because both sell microbiological consumables and QC tools into pharmaceutical manufacturing and laboratory customers.
• Veltek Associates: Specialist manufacturer of cleanroom and contamination control products used in pharmaceutical and medical device manufacturing, including environmental monitoring consumables. Comparable to Stratix Labs because both supply contamination control and surface sampling products to pharma manufacturers.
• Microbiologics: Manufacturer of microbial reference strains, QC controls, and proficiency testing consumables used in pharmaceutical, clinical, and food microbiology laboratories. Closely comparable to Stratix Labs because both supply microbial QC materials and competency/validation tools to regulated laboratory customers.

Broad incumbents

• Bio-Rad Laboratories: Manufacturer of clinical and life science research instruments, including QC microbiology kits and laboratory quality controls. Comparable to Stratix Labs because both supply analytical and microbiological QC products to pharmaceutical and clinical laboratory customers.
• bioMérieux: Global leader in industrial and clinical microbiology, including pharmaceutical QC, sterility testing, and environmental monitoring solutions. Directly comparable to Stratix Labs because both sell microbiology QC products and consumables to pharmaceutical manufacturers, though bioMérieux operates a much broader portfolio.
• Sotera Health (Nelson Labs): Parent of Nelson Labs, providing microbiology, sterility, and analytical testing services to medical device and pharmaceutical manufacturers. Comparable to Stratix Labs because both support pharmaceutical sterility assurance and microbiology QC workflows across regulated manufacturers.
• MilliporeSigma (Merck KGaA Life Science): Global life science supplier offering microbiology test kits, sterility and endotoxin reagents, and environmental monitoring consumables to pharmaceutical manufacturers. Comparable to Stratix Labs because both serve pharma QC buyers with microbiological testing and contamination control products.
• Charles River Laboratories: Major CRO offering microbiology and sterility testing services plus QC products to pharmaceutical and biopharmaceutical manufacturers. Comparable because Charles River serves the same pharmaceutical QC and sterility assurance buyers that Stratix targets, with overlapping product/service lines in endotoxin and microbial testing.

Regional players

• Neogen (3M Food Safety): Provider of food safety, sanitation, and environmental monitoring testing products across food, beverage, and adjacent regulated industries. Comparable to Stratix Labs because both sell environmental monitoring and microbial QC consumables, though Neogen's core focus is food safety rather than pharmaceutical manufacturing.

Emerging players

• Rapid Micro Biosystems: Provider of automated rapid microbial detection systems for pharmaceutical manufacturing QC and sterility testing. Comparable to Stratix Labs because both target pharmaceutical QC/sterility assurance workflows with microbiology innovation, though Rapid Micro focuses on instrumentation versus Stratix's consumable kit approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stratix Labs